164 related articles for article (PubMed ID: 24104712)
21. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
Bae K; Nam SW; Kang SW; Kim ES; Yu SY; Kim KT; Kim SJ
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):279-288. PubMed ID: 30564905
[TBL] [Abstract][Full Text] [Related]
22. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report.
Al-Awadi A; Mandelcorn ED; Somani S
Can J Ophthalmol; 2017 Feb; 52(1):e38-e41. PubMed ID: 28237171
[No Abstract] [Full Text] [Related]
23. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
Song IS; Shin YU; Lee BR
Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and therapeutic challenges.
Hirayama M; Yuzawa M; Takada M; Hirayama K; Lujan BJ; Sadda SR; Keane PA
Retina; 2011 May; 31(5):998-1003. PubMed ID: 21157396
[No Abstract] [Full Text] [Related]
25. Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities.
Kaye R; Chandra S; Sheth J; Boon CJF; Sivaprasad S; Lotery A
Prog Retin Eye Res; 2020 Nov; 79():100865. PubMed ID: 32407978
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
27. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
Dysli C; Berger L; Wolf S; Zinkernagel MS
Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
[TBL] [Abstract][Full Text] [Related]
28. Retinal pigment epithelium aperture in acute central serous chorioretinopathy: Another novel possible pathological mechanism.
Lei C; Hua R; Duan J; Zhang M
Eur J Ophthalmol; 2022 Jul; 32(4):NP103-NP108. PubMed ID: 33719657
[TBL] [Abstract][Full Text] [Related]
29. Hip-implant related chorio-retinal cobalt toxicity.
Ng SK; Ebneter A; Gilhotra JS
Indian J Ophthalmol; 2013; 61(1):35-7. PubMed ID: 23275221
[TBL] [Abstract][Full Text] [Related]
30. DIFFUSE CHORIORETINOPATHY WITHOUT SEROUS DETACHMENT ASSOCIATED WITH CARDIAC TRANSPLANTATION.
Marmor MF
Retin Cases Brief Rep; 2020; 14(3):282-288. PubMed ID: 29342012
[TBL] [Abstract][Full Text] [Related]
31. Quetiapine associated Central Serous Chorioretinopathy: Implicit role of serotonin and dopamine pathways.
Jain M
Indian J Ophthalmol; 2019 Feb; 67(2):292-294. PubMed ID: 30672500
[TBL] [Abstract][Full Text] [Related]
32. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
[TBL] [Abstract][Full Text] [Related]
33. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
34. Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography.
Roberts P; Baumann B; Lammer J; Gerendas B; Kroisamer J; Bühl W; Pircher M; Hitzenberger CK; Schmidt-Erfurth U; Sacu S
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1595-603. PubMed ID: 27046123
[TBL] [Abstract][Full Text] [Related]
35. Annular Lesions and Catenary Forms in Chronic Central Serous Chorioretinopathy.
Dansingani KK; Balaratnasingam C; Mrejen S; Inoue M; Freund KB; Klancnik JM; Yannuzzi LA
Am J Ophthalmol; 2016 Jun; 166():60-67. PubMed ID: 27021439
[TBL] [Abstract][Full Text] [Related]
36. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
37. CHOROIDAL THICKNESS CHANGES IN A PATIENT DIAGNOSED WITH CENTRAL SEROUS CHORIORETINOPATHY DURING FOLLOW-UP FOR PACHYCHOROID PIGMENT EPITHELIOPATHY.
Saito W; Hashimoto Y; Hirooka K; Ishida S
Retin Cases Brief Rep; 2021 Jan; 15(1):10-14. PubMed ID: 29470299
[TBL] [Abstract][Full Text] [Related]
38. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
Imamura Y; Fujiwara T; Spaide RF
Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous closure of retinal pigment epithelium microrip in the natural course of central serous chorioretinopathy.
Gupta V; Gupta P; Dogra MR; Gupta A
Eye (Lond); 2010 Apr; 24(4):595-9. PubMed ID: 19648895
[TBL] [Abstract][Full Text] [Related]
40. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
Hwang H; Kim JY; Kim KT; Chae JB; Kim DY
Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
